Neue Novavax: Anstieg nach 1:20 Re-Split

Hatte die Kauforder heute morgen schon eingegeben und dann doch nicht zugeschlagen. Ärgerlich...
Kann allerdings keine News finden außer dem Typ bei Marketwatch der schreibt, er hätte schon die Impfung von Novavax erhalten...
www.marketwatch.com/story/...the-novavax-underdog-11606393298

Jemand andere Informationen?  

Vom 25.11.2020
Novavax announced that it will participate in two upcoming investor conferences. Novavax’ COVID-19 vaccine candidate, NVX-CoV2373, will be a topic of discussion in each conference.

ir.novavax.com/news-releases/...icipate-upcoming-conferences-0

aller vorherigen Ereignisse überfällig. Ich denke 2021 wird Novavax mit NVX-CoV2373 ihren ersten Impfstoff auf den Markt bringen.  

gewesen zu sein:

Why Moderna and Novavax Shares Are Racing Higher Today

www.fool.com/investing/2020/11/27/...res-are-racing-higher-t/

Novavax pro 5 %

+ pro Tag tanzt für Euch alle jetzt jeweils ein Luigi ein Freudentänzchen:

____________________________

testing, manufacturing & distributing vaccine.

Alleging serious side-effects, vaccine trial participant seeks Rs 5 cr from Serum Institute

theprint.in/health/...ks-rs-5-cr-from-serum-institute/553842/

dieser Satz  
" Daten für Impfstoffkandidaten von Johnson & Johnson und Novavax Inc. werden in den kommenden Monaten erwartet. "
wie lange wird es denn nun noch dauern ,
da ist ja Biontech und Pfizer schon stark am Produzieren
nicht so gut für unsere Aktie

Novavax Impfstoff hat folgenden Vorteil und wird so weltweit eingesetzt:

-mindestens sechs Monate bei 2 ° C bis 8 ° C und mindestens 24 Stunden bei Raumtemperatur haltbar

Ich behaupte mal es spielt bei COVAX eine sehr wichtige Rolle.
Merkel hat beim G20 auch für COVAX und der WHO geworben.

Impfstoff-Initiative Covax und WHO

www.aerztezeitung.de/Politik/...fr3qL4beJFUXtaVvIFhILTF6GLuVs

images.app.goo.gl/Mg4LHYG1NruFZLYJ6

na mal sehen welche richtung der kurs am montag nimmt , denn die 22% von gestern waren schon
heftig
dir noch einen schönen ersten advent

Montag geht die Spielerei weiter, bis die Fakten kommen.

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate

Analysis of safety and immunogenicity of the Novavax SARS-CoV-2-3Q-2P-FL immunogen in mice and baboons revealed strong B and T cell responses to the vaccine with no evidence of vaccine-associated enhanced respiratory disease (15). Phase 1 and 2 clinical trial results showed that the vaccine induced immune responses exceeding levels seen in COVID-19 patients (31). Overall, we found that NVAX-CoV2372 is stable, homogeneous, and locked in the antigenically preferred prefusion conformation. With structural, biophysical, and antigenic characterization now complete, ongoing evaluation in humans will provide the true proof-of-principle for this vaccine concept.

science.sciencemag.org/content/370/6520/1089

Development Progress

Pivotal Phase 3 trial in United Kingdom completes enrollment

Phase 2b efficacy trial in South Africa completes enrollment

U.S./Mexico Phase 3 trial expected to begin in the coming weeks

ir.novavax.com/news-releases/...fI_5Al2zdFSSSOXHFc2Gu2VfLhIe0

to Late-Stage U.S. Coronavirus Vaccine Trial

finance.yahoo.com/m/...974851/novavax-shares-slide-after.html

youtu.be/QwU1IYpyI4s

the comeback players at Novavax face big questions about their best-in-class hunt in a frenzied Covid-19 vaccine race


“The likelihood of success here is so high,” Novavax R&D chief Gregory Glenn said. “It feels like climbing the mountain, and it’s hard to wait.”

endpts.com/...class-hunt-in-a-frenzied-covid-19-vaccine-race/

with Novavax to purchase COVID-19 vaccine

www.jpost.com/israel-news/...esday-as-criteria-changed-650916

o stock up on Covid-19 vaccines  

...Data shows that the key vaccine India is banking on is Novavax. The country has managed the maximum dose of Novavax vaccine (One billion doses) while dealing with Oxford-AstraZeneca for half a billion.

www.indiatoday.in/diu/story/...us-vaccines-1746188-2020-12-03

COVID Vaccine Winner Than Pfizer and Moderna

www.fool.com/investing/2020/11/30/...er-covid-vaccine-winner/

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

...the key features of these antibodies are their ability to neutralize virus, and they have been shown to be highly protective in multiple studies using multiple constructs.

... Taken together, our findings indicate that the adjuvanted, recombinant, full-length spike protein nanoparticle vaccine NVX-CoV2373 is a promising candidate that warrants testing in efficacy studies. Phase 2 has commenced on the basis of the safety results of the day 35 primary analysis, and phase 3 is in preparatory stages.

www.nejm.org/doi/full/10.1056/NEJMoa2026920

Novavax Appoints Vaccine Industry Expert Margaret G. McGlynn to Board of Directors

ir.novavax.com/news-releases/...try-expert-margaret-g-mcglynn

The world's largest vaccine producer will manufacture AstraZeneca Plc's Covishield and another formulation developed by U.S. rival Novavax Inc . Organizations such the GAVI vaccine group and the Bill & Melinda Gates Foundation are backing both candidates for large-scale distribution around the globe.

de.reuters.com/article/...M27E9nJn-1UP13PKXtvkFgaoCqUeoDM-Kac

interessante Insider-Trades

www.gurufocus.com/stock/NVAX/insider?search=novavax

Hallo

habe gerade ein gutes Video zum Thema Impfstoff Gewinner, abseits von den Impfstoffherstellern gefunden. Vielleicht für wen interessant... Anbei der Link: https://www.youtube.com/watch?v=OYf7hyeHvU4  

Lg